BD innovation highlights new flow cytometry tech

By Monish Makena, The Science Advisory Board contributing writer

January 24, 2022 -- A new study conducted by Becton Dickinson (BD) in collaboration with the European Molecular Biology Laboratory (EMBL), which was published as the cover story of Science on January 20, profiles a BD innovation in flow cytometry that adds fluorescence imaging and image-based decisioning to sort individual cells at an exceptionally high speed.

The technology is based on the visual details of each cell and not solely on the type or quantity of biomarkers that are present and has the potential to transform immunology, cell biology, and genomics research to enable new cell-based therapeutic discovery.

The new innovation from BD, known as BD CellView Image Technology, can capture multiple images of individual cells flowing through the system at a speed of 15,000 cells per second. It adds a previously impossible capability of sorting cells based on detailed microscopic image analysis of individual cells at this speed.

By imaging the distribution of biomarkers with this technology, researchers can obtain detailed information about cells that was previously invisible in traditional flow cytometry experiments. This enables scientists to answer complex biological questions, such as how cells grow, function, and interact. It also allows researchers to study exact locations of viruses or proteins within a cell -- all at a highly accelerated pace.

Image-enabled cell sorting identifies and isolates cells of interest out of a complex pool of cells at speeds of up to 15,000 cells per second.
Image-enabled cell sorting identifies and isolates cells of interest out of a complex pool of cells at speeds of up to 15,000 cells per second. Image courtesy of Tobias Wuestefeld/BlueClay Studios.

In the study, researchers used BD CellView Image Technology to study regulators of the nuclear factor kappa light chain enhancer of activated B cells (NF-κB) pathway. NF-κB is a protein complex that plays an important role in cellular immunity and stress response. The EMBL team measured the activity in this pathway by tracking the location of RelA, an REL-associated protein involved in NF-κB heterodimer formation, nuclear translocation, and activation that moves from the cytoplasm into the nucleus of the cell upon activation.

Using BD CellView Image Technology, the screen allowed the scientists to identify several novel regulators of this important cellular pathway in a matter of hours, instead of days, as would be required using conventional approaches. These results have broad implications for accelerating the pace of genomic research and therapeutic discovery, according to the team.

Copyright © 2022
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here